Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Boost IORT in breast cancer: Peruvian experience

Intraoperative radiotherapy for brain tumours

Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies

Talazoparib and enzalutamide combination therapy shows significant benefit in treating mCRPC

Belzutifan is more efficacious than everolimus in the treatment of metastatic renal cell carcinoma

Mevrometostat and enzalutamide show improved outcomes compared to enzalutamide alone in mCRPC

ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Time to metastasis after prostatectomy should not be used as a prognostic factor for metachronous mHSPC

Combining chemotherapy with cemiplimab for advanced penile cancer may serve as a viable first-line treatment option

KIM-1 is a good prognostic and predictive biomarker in advanced renal cell carcinoma

Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer